Gå til indhold
Global sound
Primary Care Voice

Primary Care Voice

Wegovy and Zepbound Denials

· 13 min. · Episode 145

Episodebeskrivelse

GLP-1 Medication Denials Explained: Wegovy, Zepbound, Ozempic & Mounjaro | Appeals, Medicare Bridge & Next Steps Dr. Kulmeet Kundlas explains why GLP-1 agonist prescriptions (Wegovy, Zepbound, Ozempic, Mounjaro) are frequently denied and how patients can navigate the process. He distinguishes denials based on whether the drug is prescribed for weight loss versus metabolic health conditions such as diabetes, sleep apnea, and fatty liver/NASH/MASH, noting that coverage rules differ. He discusses high cash prices ($1,000–$1,400), employer benefit exclusions, and how insurers verify approved…

Website: primarycarevoice.podbean.com

Live, seneste time: 14.128 sange på 6.320 stationer i 142 lande

Opdag verden gennem radioen

Flere måder at opdage på (7)

Hørt noget godt? Gem det, eller åbn det direkte i Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
Lite 105 Internet RadioFortsæt med at lytte